FDA Clearance Tracker · P930016-S045
IDESIGN ADVANCED WAVESCAN STUDIO, STAR EXCIMER LASER SYSTEM
Last checked: Nov 20, 2026Latest source record: Nov 14, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Nov 14, 2016
Approved
Time to decision
532 days
Received Jun 1, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P930016-S045
- Device name
- IDESIGN ADVANCED WAVESCAN STUDIO, STAR EXCIMER LASER SYSTEM
- Applicant
- Amo Manufacturing USA, LLC
- Applicant location
- Milpitas, CA
- Received
- Jun 1, 2015
- Decided
- Nov 14, 2016
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P930016
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the STAR S4 IR Excimer Laser System and iDesign Advanced WaveScan Studio Indication System is indicated for wavefront-guided laser assisted in situ keratomileusis (LASIK) for Use: in patients:1) with mixed astigmatism as measured by iDesign Advanced WaveScan Studio System where the magnitude of cylinder (1.0 to 5.0 D) is greater than the magnitude of sphere, and the cylinder and sphere have opposite signs; 2) with agreement between manifest refraction (adjusted for optical infinity) and iDesign Advanced WaveScan Studio System refraction as follows:a) Spherical Equivalent: Magnitude of the difference is less than 0.625 D; b)Cylinder: Magnitude of the difference is less than or equal to 0.5 D.; and c) 18 years of age or older, and with refractive stability (a change of <=1.0 D in sphere or cylinder for a minimum of 12 months prior to surgery).
Source documents
Other decisions for Amo Manufacturing USA, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223838 · Decided Apr 12, 2023 · 111 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K220516 · Decided May 17, 2022 · 83 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K210701 · Decided Apr 7, 2021 · 29 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.